Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines | Synapse

January 22, 2016Open Access

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Based on our preclinical results, we suggest analyzing the predictive value of the BCRP in breast cancer patients scheduled for irinotecan treatment. Moreover, LMP400 should be tested in a clinical setting in breast cancer patients with resistance to irinotecan.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Jandu et al. (Fri,) studied this question.

synapsesocial.com/papers/69d7c6057392c8ce61beda70 https://doi.org/https://doi.org/10.1186/s12885-016-2071-1